Navigation Links
Ajinomoto Co.'s Capsiate Natura® Reaches New Milestone
Date:3/7/2011

FORT LEE, N.J., March 7, 2011 /PRNewswire/ -- Ajinomoto Co., a leader in the development of pharmaceutical-quality amino acids and safe, effective nutraceutical solutions, has announced that its patented dietary supplement Capsiate Natura® has been granted federal trademark registration, (®), on the Principal Register of the United States Patent and Trademark Office.  The trademark is the latest milestone for Capsiate Natura®, the first and only dietary supplement with natural capsinoids extracted from the CH-19 Sweet pepper.  Extensively researched in the US and Japan, Capsiate Natura® has been shown to boost the body's metabolism* without a burning sensation and other side-effect concerns.

"While most weight management aids focus on the caloric intake, Capsiate Natura® is unique in targeting the other side of the equation, the caloric output," said Brendan Naulty, president of Ajinomoto Food Ingredients.  "Increasing the body's metabolism to burn more calories can be as important to weight management as diet and exercise."  

The CH-19 Sweet pepper, a non-pungent variety of pepper discovered by Japanese plant biologists and grown by Ajinomoto Co. exclusively in Thailand, is the unique source of capsinoids, the key ingredient in Capsiate Natura®.   Ten thousand pounds of CH-19 Sweet pepper yield just one pound of capsinoids which, unlike regular hot pepper extracts, are non-burning to the stomach and are safe partly because of no cardiovascular side effects, which is very important in therapeutic use.   Capsinoids' safety and efficacy have been researched in nearly 50 extensive studies conducted in Japan, Europe and US to date.

First introduced in the US in 2007, Capsiate Natura® is available exclusively through medical professionals.  Today, over 200 doctors are distributing the product and recommending it to their patients as a unique addition to their weight management regimen.  The network of doctors includes over 100 physicians affiliated with The Center for Medical Weight Loss (www.centerformedicalweightloss.com).

"Capsiate Natura® delivers the thermogenic punch of capsaicin without the pungency or any adverse effects," said Dr. Michael Kaplan, a founder and Chief Medical Officer of The Center for Medical Weight Loss.  "I consistently recommend it to patients who prefer a natural approach in conjunction with our own program or want to jumpstart their metabolism to avoid the natural slowing or plateau that often occurs in weight management."

Capsiate Natura® has successfully completed the Food and Drug Administration's New Dietary Ingredient (NDI) notification process, a complex pre-market evaluation procedure.

About Ajinomoto Co.

Founded in Japan in 1909, Ajinomoto Co. is a leader in the development of pharmaceutical-quality amino acids and safe, effective nutraceutical solutions to help people manage their weight, improve sleep quality and maintain healthy blood pressure levels already within the normal range*, delivering products backed by rigorous clinical studies.  For more information and a complete list of healthcare professionals that carry Ajinomoto Co.'s nutraceuticals, visit www.capsiatenatura.com, www.glysom.com and www.naturaguardbp.com

Capsiate Natura® clinical studies and White Paper available on request.

*These statements have not been evaluated by the Food and Drug Administration.  This product is not intended to diagnose, treat, cure, or prevent any disease.


'/>"/>
SOURCE Ajinomoto Co.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Enrollment Reaches 110 Patients in Investigator Initiated, Randomized Trial of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM)
2. Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter
3. CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
4. Cancer Pioneer Reaches Key Agreement on Colon Cancer Drug OncoVAX(R)
5. CureHIV Reaches Out to Bill and Melinda Gates to Fund LiSAVIOR
6. Genmab Reaches Milestone in Ofatumumab Collaboration
7. Neurobiological Technologies Reaches Patient Enrollment Target For Interim Analysis of Viprinex(TM) Phase 3 Stroke Trials
8. AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108
9. Catalyst Reaches Enrollment Target for its U.S. Phase II Cocaine Trial
10. R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges
11. Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 According to ... Type (Standard Pen Needles, Safety Pen Needles), Needle Length ... Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends ... report studies the market for the forecast period of ... USD 2.81 Billion by 2021 from USD 1.65 Billion ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced ... as its e-clinical software solution of choice.  This ... best possible value to their clients by offering ... The preferred relationship establishes nowEDC as the EDC ... for MedSource,s full-service clients.  "nowEDC has long been ...
(Date:6/23/2016)... 23, 2016  In a startling report released today, National ... by lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... of how states are tackling the worst drug crisis in recorded ... – Kentucky , New Mexico ... . Of the 28 failing states, three – Michigan ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
(Date:6/24/2016)... ... 2016 , ... National recruitment firm Slone Partners is pleased to ... genomics experience, as Vice President of North American Capital Sales at HTG Molecular ... the sales team in the commercialization of the HTG EdgeSeq system and associated reagents ...
(Date:6/24/2016)... ... ... Finally, a bruise cream that really works. Originally designed to reduce ... post-surgical treatment plans of a variety of other procedures including, but not limited to, ... bruising and causes a rapid resolution of bruising and inflammatory changes compared to no ...
(Date:6/24/2016)... ... 24, 2016 , ... SpiritQuest Sedona Retreats, located in Arizona has re-located to ... vortex sites: Cathedral Rock, Airport Mesa, and Boynton Canyon. The new retreat center ... as well as the Sedona Rouge, both popular accommodations for SpiritQuest clients. The ...
(Date:6/23/2016)... ... 23, 2016 , ... vcfo, a consulting firm that provides ... announce the promotion of Mike Mackey to Regional Vice President of Southeast Texas. ... responsible for managing client projects and overseeing vcfo financial consultants in the Houston ...
Breaking Medicine News(10 mins):